DeCoursey Thomas E
Department of Molecular Biophysics and Physiology, Rush University, Chicago, IL, USA.
Immunol Rev. 2016 Sep;273(1):194-218. doi: 10.1111/imr.12437.
One of the most fascinating and exciting periods in my scientific career entailed dissecting the symbiotic relationship between two membrane transporters, the Nicotinamide adenine dinucleotide phosphate reduced form (NADPH) oxidase complex and voltage-gated proton channels (HV 1). By the time I entered this field, there had already been substantial progress toward understanding NADPH oxidase, but HV 1 were known only to a tiny handful of cognoscenti around the world. Having identified the first proton currents in mammalian cells in 1991, I needed to find a clear function for these molecules if the work was to become fundable. The then-recent discoveries of Henderson, Chappell, and colleagues in 1987-1988 that led them to hypothesize interactions of both molecules during the respiratory burst of phagocytes provided an excellent opportunity. In a nutshell, both transporters function by moving electrical charge across the membrane: NADPH oxidase moves electrons and HV 1 moves protons. The consequences of electrogenic NADPH oxidase activity on both membrane potential and pH strongly self-limit this enzyme. Fortunately, both consequences specifically activate HV 1, and HV 1 activity counteracts both consequences, a kind of yin-yang relationship. Notwithstanding a decade starting in 1995 when many believed the opposite, these are two separate molecules that function independently despite their being functionally interdependent in phagocytes. The relationship between NADPH oxidase and HV 1 has become a paradigm that somewhat surprisingly has now extended well beyond the phagocyte NADPH oxidase - an industrial strength producer of reactive oxygen species (ROS) - to myriad other cells that produce orders of magnitude less ROS for signaling purposes. These cells with their seven NADPH oxidase (NOX) isoforms provide a vast realm of mechanistic obscurity that will occupy future studies for years to come.
我科学职业生涯中最引人入胜且令人兴奋的时期之一,是剖析两种膜转运蛋白——烟酰胺腺嘌呤二核苷酸磷酸还原形式(NADPH)氧化酶复合体和电压门控质子通道(HV 1)之间的共生关系。在我进入这个领域时,对于理解NADPH氧化酶已经取得了重大进展,但当时全世界只有极少数的专业人士了解HV 1。1991年我在哺乳动物细胞中首次发现质子电流后,如果这项工作想要获得资金支持,就需要找到这些分子的明确功能。1987 - 1988年亨德森、查佩尔及其同事的最新发现,使他们推测这两种分子在吞噬细胞呼吸爆发过程中存在相互作用,这提供了一个绝佳的机会。简而言之,这两种转运蛋白都通过跨膜移动电荷来发挥作用:NADPH氧化酶移动电子,HV 1移动质子。NADPH氧化酶的产电活性对膜电位和pH值的影响会强烈地自我限制这种酶的活性。幸运的是,这两种影响都能特异性地激活HV 1,而HV 1的活性则能抵消这两种影响,这是一种阴阳关系。尽管从1995年开始的十年里,许多人持相反观点,但这是两个独立的分子,尽管它们在吞噬细胞中功能相互依赖,但仍独立发挥作用。NADPH氧化酶和HV 1之间的关系已经成为一种范例,令人惊讶的是,它现在已经远远超出了吞噬细胞NADPH氧化酶(一种强大的活性氧(ROS)产生者),扩展到了其他产生ROS数量少几个数量级用于信号传导目的的众多细胞。这些细胞及其七种NADPH氧化酶(NOX)同工型提供了一个巨大的机制模糊领域,将占据未来数年的研究。